Omalizumab: a potential new therapeutic approach for aspirin-exacerbated respiratory disease

J Investig Allergol Clin Immunol. 2010;20(5):448-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antigens, Plant / immunology*
  • Asthma, Aspirin-Induced / diagnosis
  • Asthma, Aspirin-Induced / etiology*
  • Asthma, Aspirin-Induced / physiopathology
  • Asthma, Aspirin-Induced / prevention & control
  • Bronchial Spasm
  • Common Cold / complications
  • Common Cold / diagnosis
  • Common Cold / drug therapy*
  • Common Cold / physiopathology
  • Female
  • Humans
  • Ibuprofen / administration & dosage
  • Ibuprofen / adverse effects
  • Nasal Obstruction
  • Omalizumab
  • Poaceae
  • Pollen
  • Quality of Life
  • Respiratory Function Tests
  • Rhinitis, Allergic, Seasonal / complications
  • Rhinitis, Allergic, Seasonal / diagnosis
  • Rhinitis, Allergic, Seasonal / drug therapy*
  • Rhinitis, Allergic, Seasonal / physiopathology

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, Plant
  • Omalizumab
  • Ibuprofen